{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Gadolinium-based+contrast+agent+%28GBCA%29", "query": { "intervention": "Gadolinium-based contrast agent (GBCA)" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 23, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Gadolinium-based+contrast+agent+%28GBCA%29&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-11-04T15:14:26.116Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04373564", "title": "Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Motor Function", "Cognitive Function", "Contrast Media" ], "interventions": [ { "name": "Motor Tests", "type": "PROCEDURE" }, { "name": "Cognitive Tests", "type": "PROCEDURE" }, { "name": "Unenhanced-MRI of the brain", "type": "PROCEDURE" }, { "name": "Gadolinium Measurements", "type": "PROCEDURE" }, { "name": "Gadoxetate disodium", "type": "DRUG" }, { "name": "Gadobenate dimeglumine", "type": "DRUG" }, { "name": "Gadodiamide", "type": "DRUG" }, { "name": "Gadoterate meglumine", "type": "DRUG" }, { "name": "Gadobutrol", "type": "DRUG" }, { "name": "Gadoteridol", "type": "DRUG" } ], "intervention_types": [ "PROCEDURE", "DRUG" ], "sponsor": "Guerbet", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "18 Years to 64 Years" }, "enrollment_count": 2076, "start_date": "2021-03-24", "completion_date": "2028-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 16, "location_summary": "Scottsdale, Arizona • New Haven, Connecticut • Chicago, Illinois + 11 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Peoria", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04373564" }, { "nct_id": "NCT04867954", "title": "Development of 4D Flow MRI for Risk Stratification of Variceal Bleeding in Cirrhosis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cirrhosis, Liver", "Gastroesophageal Varices", "Fontan Procedure" ], "interventions": [ { "name": "Ensure Plus®", "type": "OTHER" }, { "name": "Pre-clinical validation contrast enhanced MRI", "type": "OTHER" }, { "name": "Clinical validation MRI", "type": "OTHER" }, { "name": "Pre-clinical validation contrast enhanced MRI + fasting", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 84, "start_date": "2021-10-28", "completion_date": "2026-06-26", "has_results": false, "last_update_posted_date": "2026-07-08", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04867954" }, { "nct_id": "NCT05615415", "title": "Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 Infection" ], "interventions": [ { "name": "PET Tracer", "type": "DRUG" }, { "name": "MRI Tracer", "type": "DRUG" }, { "name": "3T PET/MRI", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": null, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 30, "start_date": "2022-02-15", "completion_date": "2027-12-31", "has_results": false, "last_update_posted_date": "2026-09-30", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT05615415" }, { "nct_id": "NCT04661657", "title": "COvid-19 LongitUdinal Multiethnic BioImaging Assessment of CARDiovascular Sequelae Registry", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Covid19", "Cardiac Disease", "Cardiac Arrhythmia", "Myocarditis", "Left Ventricular Dysfunction" ], "interventions": [ { "name": "Transthoracic echocardiogram (TTE)", "type": "OTHER" }, { "name": "Cardiovascular Magnetic Resonance (CMR) Imaging", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 52, "start_date": "2020-12-28", "completion_date": "2022-01-22", "has_results": false, "last_update_posted_date": "2022-06-06", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04661657" }, { "nct_id": "NCT01014754", "title": "Nephrogenic Systemic Fibrosis (NSF): Analysis of Tissue Gadolinium Levels", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Nephrogenic Systemic Fibrosis", "Nephrogenic Fibrosing Dermopathy" ], "interventions": [], "intervention_types": [], "sponsor": "Northwestern University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 24, "start_date": "2007-08", "completion_date": "2014-06", "has_results": false, "last_update_posted_date": "2014-12-04", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014754" }, { "nct_id": "NCT04307186", "title": "Study to Find the Appropriate Dose of a New Gadolinium-based Contrast Agent (GBCA) for Adults Undergoing Magnetic Resonance Imaging (MRI) for Known or Highly Suspected Brain and/or Spinal Cord Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Central Nervous System Pathology" ], "interventions": [ { "name": "Gadoquatrane (BAY1747846)", "type": "DRUG" }, { "name": "Gadobutrol (Gadovist/Gadavist)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 57, "start_date": "2020-11-18", "completion_date": "2022-09-06", "has_results": true, "last_update_posted_date": "2023-11-15", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 3, "location_summary": "Chicago, Illinois • Iowa City, Iowa • Hershey, Pennsylvania", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Hershey", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT04307186" }, { "nct_id": "NCT03180021", "title": "Dynamic Imaging of Variation in Lupus Nephritis", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Lupus Nephritis" ], "interventions": [ { "name": "MRI", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "RILITE Foundation", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 21, "start_date": "2018-03-13", "completion_date": "2020-10-02", "has_results": false, "last_update_posted_date": "2021-10-04", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 6, "location_summary": "Aurora, Colorado • New York, New York • Columbus, Ohio + 2 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "New York", "state": "New York" }, { "city": "New York", "state": "New York" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03180021" }, { "nct_id": "NCT05915702", "title": "A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Contrast Enhancement in Magnetic Resonance Imaging", "Central Nervous System Pathology" ], "interventions": [ { "name": "Gadoquatrane (BAY1747846)", "type": "DRUG" }, { "name": "Gadobutrol", "type": "DRUG" }, { "name": "Gadoterate meglumine", "type": "DRUG" }, { "name": "Gadoteridol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 321, "start_date": "2023-07-24", "completion_date": "2024-05-31", "has_results": true, "last_update_posted_date": "2026-10-08", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 8, "location_summary": "Indian Wells, California • Orange, California • Miami, Florida + 5 more", "locations": [ { "city": "Indian Wells", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Farmington Hills", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT05915702" }, { "nct_id": "NCT05061979", "title": "A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Contrast Enhancement in Magnetic Resonance Imaging" ], "interventions": [ { "name": "BAY1747846", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 24, "start_date": "2021-10-12", "completion_date": "2022-07-14", "has_results": false, "last_update_posted_date": "2022-11-21", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 2, "location_summary": "Miami, Florida • Knoxville, Tennessee", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05061979" }, { "nct_id": "NCT07910474", "title": "FES PET/MRI for Occult Disease in Lobular Breast Cancer", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Lobular Breast Carcinoma" ], "interventions": [ { "name": "18Fluoroestradiol (18F-FES)", "type": "DRUG" }, { "name": "MRI", "type": "DEVICE" }, { "name": "Gadolinium-based contrast agent (GBCA)", "type": "DRUG" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2026-11", "completion_date": "2028-11", "has_results": false, "last_update_posted_date": "2026-11-03", "last_synced_at": "2026-11-04T15:14:26.116Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT07910474" } ] }